Cargando…

Polymer Nanoparticles for Nanomedicines A Guide for their Design, Preparation and Development /

Nanomedicines comprise a wide range of nanotechnologies including various types of nanoparticles developed as therapeutic, diagnostic and theranostic agents. The translation of nanoparticles in the clinical setting is rapidly progressing. It is now a quite well-established idea that the ultimate in...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Vauthier, Christine (Editor ), Ponchel, Gilles (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2016.
Edición:1st ed. 2016.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-41421-8
003 DE-He213
005 20220119041802.0
007 cr nn 008mamaa
008 170107s2016 sz | s |||| 0|eng d
020 |a 9783319414218  |9 978-3-319-41421-8 
024 7 |a 10.1007/978-3-319-41421-8  |2 doi 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a PNB  |2 thema 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Polymer Nanoparticles for Nanomedicines  |h [electronic resource] :  |b A Guide for their Design, Preparation and Development /  |c edited by Christine Vauthier, Gilles Ponchel. 
250 |a 1st ed. 2016. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2016. 
300 |a XXIX, 641 p. 115 illus., 80 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Preface -- Introduction Part I: Polymer nanoparticles for in vivo applications: Progress on preparation methods and future challenges -- Nanoprecipitation process: From particlepreparation to in vivo applications -- Targeted Theragnostic Nanoparticles via Flash Nanoprecipitation: Principles of Materials Selection -- Preparation of polymer nanoparticles by the emulsification-solvent evaporation method: from Vanderhoff´s pioneer approach to recent adaptations -- Methods for the preparation of nanoparticles by polymerization -- Shape-controlled nanoparticles for drug delivery and targeting applications -- Physicochemical characterization of polymer nanoparticles: Challenges and present limitations -- Imaging polymer nanoparticles by means of transmission and scanning electron microscopy techniques -- Evaluating the interactions between proteins and components of the immune system with polymer nanoparticles -- Investigating interactions between nanoparticles and cells: internalization and intracellular trafficking -- Characterization of mucoadhesive interactions between nanoparticles and epithelial membranes -- Designing polymer nanoparticle nanomedicines: potential applications and challenges -- Selecting and designing polymers suitable for nanoparticles manufacturing -- Associating Drugs with Polymer Nanoparticles: A Challenge -- Drug delivery by nanoparticles: The Challenge of Controlled Release and Evaluation -- Interaction between nanoparticles and plasma proteins: effects on nanoparticle biodistribution and toxicity -- Toxicological aspects of polymer nanoparticles -- Theranostics: In Vivo -- Nanomedicines -A scientific toy or an emerging market? -- Regulatory perspective on the development of polymeric nanomaterials. 
520 |a Nanomedicines comprise a wide range of nanotechnologies including various types of nanoparticles developed as therapeutic, diagnostic and theranostic agents. The translation of nanoparticles in the clinical setting is rapidly progressing. It is now a quite well-established idea that the ultimate in vivo efficacy of nanoparticles is closely related to their characteristics. However, defining specification and designing nanoparticles based on scientifically sound justifications remains an obstacle. Another hurdle concerns the production of the nanoparticles in the requirements of clinical batch manufacturing and quality control. In these challenges, polymer nanoparticles are unique. Their characteristics can be finely tuned during synthesis and post-synthesis to cover the broad range of specificity that can be defined, with a high level of precision needed to make their in vivo application successful. Their methods of synthesis can be quite precise and most of them are scalable. The topic of the present book covers all steps of the development of polymer nanoparticles to be used as therapeutic or diagnostic nanomedicine. It is aimed to guide researchers, entrepreneurs, engineers, postdoctoral and Ph.D. students in their decisions for the design and development of nanomedicines occurring as polymer nanoparticles. The book is divided into four sections. The first and second parts describe experimental protocols as well as the methods of manufacturing and the methods of characterization that were specifically developed to be applied during the development of polymer-based nanomedicines. The third section includes a series of chapters that discusses the different topics that are accounted for while designing polymer-based nanomedicines to give them suitable characteristics. It covers the synthesis of polymers; the principles used to associate drugs and to achieve both drug loading and controlled release; the approaches developed to control interactions of the nanoparticles with proteins while they are in biological fluids and to control the in vivo fate of the nanoparticles; nanotoxicological aspects including the design of nanotheranostics with therapeutic and diagnostic tools in the same nanoparticles. The last section of the book gives prospective views on the development of this type of nanomedicines, considering their registration and potential market. This comprehensive book is fit for a wide audience, written by prominent researchers and top experts in the field of nanomedicines who share a web of established knowledge, point out unanswered questions, and discuss the field's bottlenecks in order to succeed in the development of nanomedicines made of polymer nanoparticles and to translate these into the clinic. The panel of authors reflects the different disciplines that cover the whole process of research and development of a polymer nanomedicine. Researchers and other field-related professionals can refer to the book from the early stages of the conception of a new nanomedicine to the later stages of development, including the preparation of registration, which needs to be started as early as possible, taking in mind that all choices will need to be justified. Developers will also find resources in this book to apply quality-by-design approaches when designing and developing polymer-based nanomedicines. Finally, we believe that this book, which aims to give a thorough picture of the state-of-the-art in the field of polymeric nanoparticles, will become a favorite book for anyone interested in the development of these nanomedicines. . 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Pharmacovigilance. 
650 0 |a Proteins . 
650 0 |a Biotechnology. 
650 1 4 |a Pharmaceutics. 
650 2 4 |a Drug Safety and Pharmacovigilance. 
650 2 4 |a Protein Biochemistry. 
650 2 4 |a Biotechnology. 
700 1 |a Vauthier, Christine.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Ponchel, Gilles.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319414195 
776 0 8 |i Printed edition:  |z 9783319414201 
776 0 8 |i Printed edition:  |z 9783319823492 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-41421-8  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)